# Ectoin Dermatitis Cream 7% as First-line Therapy of Acute Skin Graft Versus Host Disease

> **NCT02842372** · — · WITHDRAWN · sponsor: **Bitop AG**

## Conditions studied

- Acute Graft Versus Host Disease in Skin

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02842372
- **Lead sponsor:** Bitop AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-12
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study withdrawn due to difficulties in recruiting patients
- **Last updated:** 2018-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02842372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02842372, "Ectoin Dermatitis Cream 7% as First-line Therapy of Acute Skin Graft Versus Host Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02842372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*